10x Genomics (TXG) – Management Comments
-
10x Genomics (TXG) Tops Q1 EPS by 16c, Revenues Beat; Offers FY21 Revenues Mid-Point Guidance Below Consensus
-
10x Genomics (TXG) Misses Q3 EPS by 35c, Revenues Beat
-
-
-
-
Back to TXG Stock Lookup